Urinary Tract Infections (UTI)

Effect of Probenecid on Cephalexin Pharmacokinetics and Pharmacodynamics

Publish Date September 7, 2021

Researchers conducted a crossover study to determine whether probenecid and cephalexin administered together increases the clinical benefits of cephalexin.

Community-Acquired Urinary Tract Infection: Adverse Effects of Cotrimoxazole vs Fluoroquinolones

Publish Date September 3, 2021

Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.

ACP Releases Practice Advice for Short-Course Antibiotics in Common Infections

Publish Date June 4, 2021

The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.

Shorter Antibiotic Course Sufficient for Afebrile Men With UTIs

Publish Date July 28, 2021

Findings support prescribing antimicrobials for no longer than needed.

FDA Needs More Data on Sulopenem for Uncomplicated UTI

Publish Date July 28, 2021

The NDA submission was supported by data from the phase 3 SURE1 clinical trial.

Non-Antimicrobial Drugs Tied to Drug-Resistant Bacterial Infection

Publish Date July 21, 2021

Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria

High Glycosuria Environment Allows for Increased Growth, Adherence of Group B Streptococcus

Publish Date June 23, 2021

Investigators conducted a study to assess the effects of moderate glycosuria on groupB Streptococcus .

Vaginal pH Regulator Gets Fast Track Status for Gonorrhea Prevention

Publish Date May 18, 2021

EVO100 is pH-modulating vaginal gel designed to reduce certain vaginal infections by balancing vaginal pH, thereby maintaining healthy vaginal flora.

Urinary Tract Infection Prophylaxis Among Older Adults Increase Risks

Publish Date April 16, 2021

Study authors examined 186,589 patients with an initial positive urine culture and receiving antibiotics to quantify risks and benefits of UTI prophylaxis in older adults.

ACP Offers Guidance on Antibiotic Duration for Common Infections

Publish Date April 28, 2021

Best practices recommend limiting antibiotics to 5 days for COPD exacerbations, acute uncomplicated bronchitis